Business
Neogen Announces the Appointment of Two New Board Members
Board of Directors expanded in conjunction with the closing of the 3M Food Safety transaction LANSING, Mich., Sept. 12, 2022 /PRNewswire/ -- Neogen
About this update from Neogen Corporation
[{"type":"text","content":"Board of Directors expanded in conjunction with the closing of the 3M Food Safety transaction\nLANSING, Mich., Sept. 12, 2022 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG), a leader in food and animal safety, announced today that it has appointed two new members to its Board of Directors: Jeffrey Capello and Aashima Gupta. The addition of Mr. Capello and Ms. Gupta was agreed by Neogen and 3M Company under the merger agreement for the 3M Food Safety transaction.\n\"We are pleased to add these two experienced industry professionals to Neogen's Board of Directors,\" said Jim Borel, Neogen's Board Chair. \"Their involvement in the global healthcare and biotechnology industries will be a significant benefit to Neogen as the company moves into this new era, and we are confident their expertise will be valuable as Neogen continues to grow.\"\n\"The leadership and insight that both Jeff and Aashima will bring to our Board will help us continue to drive growth, enhance our global strategy, and create value for Neogen shareholders,\" said John Adent, Neogen's President and Chief Executive Officer. \"I am looking forward to working closely with them as we enter this exciting time in Neogen's growth, creating new opportunities for the company, our customers, our shareholders, and our world.\"\nJeff Capello is a senior finance executive with over 30 years of experience helping companies create significant value for their shareholders. He served as the Chief Financial Officer for publicly held and private equity-backed companies, including PerkinElmer, Boston Scientific, Ortho Clinical Diagnostic, Beacon Health Options, and Biogen. Jeff also served on the Board of Directors for several early-stage publicly held biotechnology companies as Audit Committee Chair, including Sirtris, OvaScience, and Flex Pharma. He currently is the Managing Member at Monomoy Advisors, a financial advisory firm that provides counsel to senior leadership on shareholder value creation strategies.\nAashima Gupta is a strategic global leader with over 25 years of experience working at the intersection of health and technology, with extensive experience in complex large-scale enterprise environments. She worked in technology development across a number of organizations, including NIIT, Fidelity Investments, J.P. Morgan Chase, Apigee, and Kaiser Permanente. She joine...